Fundraising Fox

Create

San Francisco, US · Founded 2020 · Delaware corporation · 3 known investors

createmedicines.com

CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

Create was founded in 2020 by Daniel Getts.

DGDaniel Getts
Daniel GettsinFounder and CEO
BKBrett Kaplan
Brett KaplaninChief Financial and Business Officer
ML
Marcus LoweNamed on SEC filing
DA
Dhruv AminNamed on SEC filing

Investors · 3

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 1 round · 2022

$2MraisedNov 2022 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marcus LoweExecutive Officer, Director
  • Dhruv AminExecutive Officer, Director
Offering amount
$3M
Amount sold
$2M
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Create for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Create do?
CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
Who founded Create?
Create was founded by Daniel Getts in 2020.
Who are Create's investors?
Create's investors include 8VC, Raptor Group, Newpath Partners.
How much funding has Create raised?
Create has disclosed $2M raised across 1 round.
Where is Create headquartered?
Create is headquartered in San Francisco, US.